Literature DB >> 12099376

Tissue distribution of calcineurin and its sensitivity to inhibition by cyclosporine.

L Kung1, T D Batiuk, S Palomo-Pinon, J Noujaim, L M Helms, P F Halloran.   

Abstract

The immunosuppressive activity of cyclosporine is mediated by inhibiting calcineurin phosphatase. However, calcineurin is widely distributed in other tissues. We examined the degree of calcineurin inhibition by cyclosporine in various tissues. In vitro, the cyclosporine concentration inhibiting 50% (IC50) of calcineurin was to approximately 10 ng/mL in human and mouse leukocytes suspensions. In vitro and in vivo IC50s of cyclosporine in homogenates of mouse kidney, heart, liver, testis, and spleen were also comparable (9-48 ng/mL). The maximum calcineurin inhibition by cyclosporine varied, from 83 to 95% of calcineurin activity in spleen, kidney, liver, and testis to 60% in heart and only 10% in brain. Maximum calcineurin inhibition was increased by the addition of cyclophilin A, indicating that cyclophilin concentrations were limiting in some tissues, at least in this assay. Western analysis of mouse tissues showed significantly less cyclophilin in heart than other tissues. cyclosporine concentrations per weight of tissue protein were highest in kidney and liver and lowest in brain and testis after oral dosing, with intermediate levels in spleen, heart, and whole blood. Thus each cyclosporine dose produces rapid and wide-spread inhibition of calcineurin in tissues, with differences in total susceptibility of each tissue.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12099376     DOI: 10.1034/j.1600-6143.2001.10407.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  12 in total

1.  Role of calcineurin in the regulation of human lung mast cell and basophil function by cyclosporine and FK506.

Authors:  C A Harrison; R Bastan; M J Peirce; M R Munday; P T Peachell
Journal:  Br J Pharmacol       Date:  2007-01-02       Impact factor: 8.739

2.  Protein phosphatase 1, protein phosphatase 2A, and calcineurin play a role in estrogen-mediated neuroprotection.

Authors:  Kun Don Yi; James W Simpkins
Journal:  Endocrinology       Date:  2008-06-19       Impact factor: 4.736

3.  Preprandial microemulsion cyclosporine administration is effective for patients with refractory nephrotic syndrome.

Authors:  Sayuri Shirai; Takashi Yasuda; Hiroki Tsuchida; Shingo Kuboshima; Yusuke Konno; Yoshinori Shima; Takeo Sato; Shigeo Hatta; Keisou Masuhara; Kenjirou Kimura
Journal:  Clin Exp Nephrol       Date:  2008-12-05       Impact factor: 2.801

4.  Measurement and compartmental modeling of the effect of CYP3A5 gene variation on systemic and intrarenal tacrolimus disposition.

Authors:  S Zheng; Y Tasnif; M F Hebert; C L Davis; Y Shitara; J C Calamia; Y S Lin; D D Shen; K E Thummel
Journal:  Clin Pharmacol Ther       Date:  2012-10-17       Impact factor: 6.875

5.  Cyclosporine inhibits mouse cytomegalovirus infection via a cyclophilin-dependent pathway specifically in neural stem/progenitor cells.

Authors:  Hideya Kawasaki; Edward S Mocarski; Isao Kosugi; Yoshihiro Tsutsui
Journal:  J Virol       Date:  2007-06-06       Impact factor: 5.103

6.  Therapeutic effects of astragaloside IV on myocardial injuries: multi-target identification and network analysis.

Authors:  Jing Zhao; Pengyuan Yang; Fan Li; Lin Tao; Hong Ding; Yaocheng Rui; Zhiwei Cao; Weidong Zhang
Journal:  PLoS One       Date:  2012-09-17       Impact factor: 3.240

7.  Acetylation regulates cyclophilin A catalysis, immunosuppression and HIV isomerization.

Authors:  Michael Lammers; Heinz Neumann; Jason W Chin; Leo C James
Journal:  Nat Chem Biol       Date:  2010-04-04       Impact factor: 15.040

8.  Investigating the human Calcineurin Interaction Network using the πɸLxVP SLiM.

Authors:  Sarah R Sheftic; Rebecca Page; Wolfgang Peti
Journal:  Sci Rep       Date:  2016-12-15       Impact factor: 4.379

9.  Drug-Integrating Amphiphilic Nanomaterial Assemblies: 1. Spatiotemporal control of cyclosporine delivery and activity using nanomicelles and nanofibrils.

Authors:  Diana Velluto; Damir Bojadzic; Teresa De Toni; Peter Buchwald; Alice A Tomei
Journal:  J Control Release       Date:  2020-10-18       Impact factor: 9.776

10.  Pharmacokinetics of cyclosporin--a microemulsion in children with idiopathic nephrotic syndrome.

Authors:  Luciana dos Santos Henriques; Fabíola de Marcos Matos; Maria Helena Vaisbich
Journal:  Clinics (Sao Paulo)       Date:  2012-10       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.